News From Industry Sources
ACSS spine surgeons hear professor F.W. Smith, M.D. report that the FONAR UPRIGHT(TM) MRI successfully diagnosed 54% of the back pain patients that could not be diagnosed by re-cumbent MRI
May 8, 2007
Many pathologies are only evident in the upright, weight-bearing position. You cannot rely on the recumbent MRI to determine the pathology that is responsible for your patient's back pain. Story
Data suggest Cymbalta(R) reduced severity of night pain in patients with diabetic nerve pain; new analysis examines impact of pain on sleep interference
May 3, 2007
Eli Lilly and Company (NYSE: LLY) today announced that data from a pooled analysis of three studies suggest that in patients with pain caused by diabetic nerve damage, or diabetic peripheral neuropathy, who are treated with Cymbalta (duloxetine HCl), improvements in both average daily pain and night pain severity were associated with less pain-related sleep interference than in those patients taking sugar pill. Story
HealthSonix launches topical pain reliever
May 03, 2007
HealthSonix, Inc. today announced that it is launching its new pain relieving cream under the ZingiberRx brand name. The launch follows 3 years of successful market research, consumer testing and clinical tests. Story
National Arthritis Month brings awareness to non-surgical and non-pharmaceutical osteoarthritis treatments
May 02, 2007
Patients seek alternatives to Cox-2 Inhibitors. Braces proven to be one of the most effective and affordable treatments for knee OA. Story
Lyrica significantly reduced pain and helped patients manage the symptoms of fibromyalgia
May 1, 2007
Significantly more Fibromyalgia patients treated with Pfizer's Lyrica reduced their pain by 50 percent or more compared with placebo, according to study results presented today at the American Academy of Neurology annual meeting. Story
Cephalon presents positive results for FENTORA(R) in breakthrough pain associated with neuropathic conditions
May 02, 2007
Phase 3 clinical trial data presented at the 59th Annual Meeting of the American Academy of Neurology (AAN) demonstrate that FENTORA (fentanyl buccal tablet) is beneficial for the treatment of breakthrough pain in patients with neuropathic pain who are already taking opioids around-the-clock to manage their persistent pain. Story
FDA approves Alpharma's KADIAN(R) new 10mg strength
April 23. 2007
Alpharma Inc., a global specialty pharmaceutical company, today announced that it has been notified by the United States Food and Drug Administration("FDA") that its pending application for KADIAN(R) 10mg strength capsule has received approval. Story
Spine Wave receives FDA clearance for the StaXx(R) FX Structural Kyphoplasty System
April 16, 2007
Spine Wave, Inc., a company that develops and markets innovative spinal surgical solutions, announced it has received FDA 510(k) clearance to market its StaXx(R) FX Structural Kyphoplasty System for the treatment of vertebral compression fractures. The minimally invasive system is designed to provide pain relief and a controlled vertical fracture reduction. Story
New pain relief cream by Honeymark
April 16, 2007
Honeymark introduces their new Pain Relief Cream that brings temporary relief of minor aches and pains associated with arthritis, simple backaches, strains and sprains. Story
|
